HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kwangho Lee Selected Research

1,1'- (4,4'- (((5- chloropyrimidine- 2,4- diyl)bis(azanediyl))bis(3- methoxy- 4,1- phenylene))bis(piperazine- 4,1- diyl))diethanone

10/2020KRCA-0008 suppresses ALK-positive anaplastic large-cell lymphoma growth.
8/2015Development of potent ALK inhibitor and its molecular inhibitory mechanism against NSCLC harboring EML4-ALK proteins.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kwangho Lee Research Topics

Disease

11Neoplasms (Cancer)
01/2022 - 12/2013
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 12/2013
3Body Weight (Weight, Body)
06/2015 - 06/2014
2Aortic Dissection
02/2022 - 12/2016
2Heart Failure
10/2020 - 04/2009
2Aneurysm (Aneurysms)
03/2018 - 12/2016
2Intracranial Aneurysm (Cerebral Aneurysm)
03/2018 - 12/2016
2Autoimmune Diseases (Autoimmune Disease)
10/2017 - 01/2016
1Pica (Geophagia)
02/2022
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2022
1Head and Neck Neoplasms (Head and Neck Cancer)
01/2022
1Breast Neoplasms (Breast Cancer)
01/2022
1Burns
12/2020
1Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
10/2020
1Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy)
10/2020
1Cardiogenic Shock
10/2020
1Liver Neoplasms (Liver Cancer)
11/2019
1Thrombosis (Thrombus)
03/2018
1Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage)
03/2018
1Rupture
03/2018
1Hemorrhage
03/2018
1Hepatocellular Carcinoma (Hepatoma)
12/2017
1Lung Neoplasms (Lung Cancer)
07/2017
1Plexiform Neurofibroma
09/2014
1Myocarditis (Carditis)
05/2012
1Clostridium Infections
03/2012
1Muscular Dystrophies (Muscular Dystrophy)
12/2010
1Pulmonary Hypertension
06/2009
1Death (Near-Death Experience)
04/2009
1Cardiovascular Diseases (Cardiovascular Disease)
04/2009
1Hyperemia
09/2008
1Myocardial Ischemia (Ischemic Heart Diseases)
02/2006
1Orthostatic Hypotension (Postural Hypotension)
02/2006
1Obesity
06/2005
1Cardiomegaly (Heart Hypertrophy)
06/2005

Drug/Important Bio-Agent (IBA)

3ErbB Receptors (EGF Receptor)IBA
01/2022 - 12/2013
3Pharmaceutical PreparationsIBA
11/2017 - 01/2016
3Proteins (Proteins, Gene)FDA Link
11/2017 - 08/2015
21,1'- (4,4'- (((5- chloropyrimidine- 2,4- diyl)bis(azanediyl))bis(3- methoxy- 4,1- phenylene))bis(piperazine- 4,1- diyl))diethanoneIBA
10/2020 - 08/2015
2Tyrosine Kinase InhibitorsIBA
12/2015 - 12/2013
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2022
1NucleophosminIBA
10/2020
1Biomarkers (Surrogate Marker)IBA
11/2019
1Tirofiban (Aggrastat)FDA Link
03/2018
1Glycoproteins (Glycoprotein)IBA
03/2018
1IndazolesIBA
12/2017
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2017
1LigandsIBA
12/2017
1QuinoxalinesIBA
10/2017
1lorlatinibIBA
07/2017
1Anaplastic Lymphoma KinaseIBA
07/2017
1Phosphotransferases (Kinase)IBA
07/2017
1Death-Associated Protein KinasesIBA
01/2016
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
01/2016
1CrizotinibIBA
08/2015
1Bee Venoms (Bee Venom)IBA
09/2014
1Gefitinib (Iressa)FDA Link
06/2014
1Hematoxylin (Haematoxylon)IBA
06/2014
1Erlotinib Hydrochloride (CP 358,774)FDA Link
06/2014
1Eosine Yellowish-(YS) (Eosin)IBA
06/2014
1alkoxyl radicalIBA
01/2014
1PyrimidinesIBA
01/2014
1TriazinesIBA
01/2014
1rociletinibIBA
12/2013
1TenascinIBA
05/2012
1LFF571IBA
03/2012
1Natriuretic PeptidesIBA
12/2010
1Brain Natriuretic Peptide (Natrecor)FDA Link
06/2009
1Adenosine Triphosphate (ATP)IBA
09/2008
1Vasoconstrictor AgentsIBA
02/2006
1LeptinIBA
06/2005
1Adrenergic Agents (Adrenergic Drugs)IBA
06/2005

Therapy/Procedure

4Stents
02/2022 - 12/2016
1Semiconductors
12/2020
1Extracorporeal Membrane Oxygenation
10/2020
1Catheters
03/2018
1Intramuscular Injections
06/2015
1Intravenous Injections
09/2014
1Oral Administration
12/2013
1Patient Readmission
04/2009
1Intravenous Infusions
09/2008